Frost & Sullivan: Climate Concerns and Emerging Markets Breathe New Life Into the European Large Hydropower Market

Frost & Sullivan to Host Analyst Briefing on the European Large Hydropower Market on Wednesday, 24 February, 2010 at 3:00 pm GMT

Rising Popularity of Home Care Underlines Rise of Care Management Markets Across Europe, Finds Frost & Sullivan

LONDON, February 16, 2010 - Europe's patient population is moving towards long-term care and homecare
from hospitals and other clinical settings. Consequently, the significance of
nursing and residential care services is on the rise. Unlike the past decade,
therefore, the number of care homes in Europe has shown an increase. At the
same time, care managers have been becoming technology savvy. As the adoption
rates of care management systems surges, the potential of care management
markets across Europe is improving.

United America Indemnity, Ltd. Announces Plans to Reincorporate in Ireland

GEORGE TOWN, Cayman Islands, February 16, 2010 - United America Indemnity, Ltd. (Nasdaq: INDM) (the "Company") announced
today that its Board of Directors has unanimously approved a plan to
re-domicile from the Cayman Islands to Ireland. The Company's shareholders
will be asked to vote in favor of completing the reorganization proposal at a
special shareholders meeting. If the proposal is accepted, the Company will
become a wholly-owned subsidiary of Global Indemnity plc., an Irish company.

PopCap Celebrates Bejeweled(R)'s 10th Birthday with Year-Long Celebration, 50 Millionth Unit Sold

Most Popular Puzzle Game Series of the 21st Century Selling Faster Today Than Ever; Anniversary Festivities Will Include New Installments, Competitions, Contests, Etc.

Devilfish Gaming Plc Launches DevilfishBingo.com

Online Bingo Players Have a Ball as Devilfish Gaming Launches DevilfishBingo.com With 100 Percent First Deposit Bonus

First Live Case in the U.K. Using Cappella's Sideguard(R) Coronary Sidebranch Stent at PCI Live

GALWAY, Ireland, November 25 - Cappella, Inc. (Cappella), a medical device company developing dynamic
solutions for the treatment of coronary bifurcation disease announced the
first U.K. cases involving the Sideguard(R) Coronary Sidebranch Stent &
Delivery System. The initial case was performed at PCI Live 2009 with the
second case following immediately thereafter, off-camera. Dr. Joseph D.
Mills, Consultant Cardiologist at the Liverpool Heart & Chest Hospital, UK
performed both procedures. According to Dr. Mills, "We see numerous
bifurcation cases & are very pleased to see that there is now a dedicated and
straightforward solution to treating complex bifurcation lesions. As the
first centre in the UK to use Sideguard, we are very satisfied with the
results."

New Shire Board Member

DUBLIN, Ireland - The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non Executive Director with effect from 31 October 2009.

Warner Chilcott Completes Acquisition of P&G’s Global Branded Prescription Pharmaceuticals Business

ARDEE, Ireland -

Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company’s global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott’s existing presence in women’s health care and adds new therapeutic and geographic markets. At closing approximately 1,900 employees of P&G’s pharmaceuticals business joined Warner Chilcott and the Company added manufacturing facilities in Germany and Puerto Rico.

PopCap Launches Zuma’s Revenge!(TM) For PC and Mac

SEATTLE, Washington and DUBLIN, Ireland -

- Sequel to Multi-Platinum Seller Boasts All-New Amphibious Action and Imagery

PopCap Launches Bookworm(TM) Adventures Volume 2

SEATTLE, Washington and DUBLIN, Ireland -

- Sequel to 2007 Hit Word Game Unearths all-new Books in the Continuing Adventures of Lex the Bookworm

Zuma(R) Web Connect Launches on PopCap.com

DUBLIN, Ireland -

- New “Social” Iteration of PopCap’s #2 Franchise Enables Friendly Zuma Competition Via Facebook Connect

Cappella Inc. Secures US$17.3 Million Series C Investment

WILMINGTON, Delaware and GALWAY, Ireland - New and existing investors complete a US$17.3 million Series C investment - Experienced medical device executive, Dr. Art Rosenthal, appointed as CEO - Aggressive launch of Sideguard(TM) Sidebranch stent in EU following recent CE Marking - Expansion of management team, R&D and manufacturing capacity in Galway, Ireland

Alimentary Health’s Probiotic Technology Launched Nationwide in the US

CORK, Ireland - Marketed as Align(R) by Procter & Gamble

Alimentary Health Ltd. (”Alimentary Health” or “the Company”), the specialty gastrointestinal company, welcomes today’s announcement from its licensing partner Procter & Gamble (P&G), that Align, a daily probiotic supplement clinically proven to naturally defend against episodic digestive upsets, is now available nationwide in the US. Previously only available on-line and through special order from pharmacists, Align is already the US’s number one gastroenterologist-recommended probiotic supplement.

Sunsail Launches the new Sunsail 384 Catamaran

CARRICK ON SHANNON, Ireland - New Generation Sailing Catamaran Ideal for Cruising

CARRICK ON SHANNON, Ireland, April 27 /PRNewswire/ –

Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009

DUBLIN, Ireland - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce first quarter 2009 earnings on Thursday April 30, 2009.

The Armada Takes to the Air

LONDONDERRY, Ireland - An Analysis of the Online Searches of European Internet Users Highlights That London is the Choice Holiday Destination This Easter

Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland - Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that it has filed a lawsuit
in the U.S. District Court of the Southern District of New York against Mylan
Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories Limited
(collectively “Mylan”) for infringement of Shire’s patent: U.S. Patent No.
5,968,976 (”‘976 Patent”).

Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland - Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that it has
filed a lawsuit in the U.S. District Court of the Southern District of New
York against Barr Laboratories, Inc. (”Barr”) for infringement of three of
Shire’s patents: U.S. Patent No. 5,968,976 (”‘976 Patent”);U.S. Patent No.
7,381,428 (”‘428″); and U.S. Patent No. 7,465,465 (”‘465″).